Orexin, orexin receptor antagonists and central cardiovascular control

Frontiers in Neuroscience

Volumn , Issue 7 DEC, 2013, Pages

  Carrive, Pascal ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Blood pressure; Heart rate; Ox1R; Ox2R; Psychological stress; Rostral ventrolateral medulla; SHR; Sympathetic

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ALMOREXANT; ANTIHYPERTENSIVE AGENT; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; OREXIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CHRONIC STRESS; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ELEVATED BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; MENTAL STRESS; NONHUMAN; PANIC; PREGANGLIONIC NERVE CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHORT SURVEY; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 84898036066     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00257     Document Type: Short Survey

References (64)

1. Antunes, V. R., Brailoiu, G. C., Kwok, E. H., Scruggs, P., and Dun, N. J. (2001). Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am. J. Physiol. 281, R1801-R1807.
2. Asahi, S., Egashira, S.-I., Matsuda, M., Iwaasa, H., Kanatani, A., Ohkubo, M., et al. (2003). Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B. Bioorg. Med. Chem. Lett. 13, 111-113.
3. Bäckberg, M., Hervieu, G., Wilson, S., and Meister, B. (2002). Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur. J. Neurosci. 15, 315-328. doi: 10.1046/j.0953-816x.2001.01859.x
4. Baldo, B. A., Daniel, R. A., Berridge, C. W., and Kelley, A. E. (2003). Overlapping distributions of orexin/hypocretin-and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 464, 220-237. doi: 10.1002/cne.10783
5. Bastianini, S., Silvani, A., Berteotti, C., Elghozi, J.-L., Franzini, C., Lenzi, P., et al. (2011). Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice. Sleep 34, 213-218.
6. Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., et al. (2007). Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat. Med. 13, 150-155. doi: 10.1038/nm1544
7. Carrive, P. (2011). "Central circulatory control. Psychological stress and the defense reaction," in Central Regulation of Autonomic Function, 2nd Edn., eds I. J. Llewellyn-Smith and A. Verberne (New York, NY: Oxford University Press), 220-237. doi: 10.1093/acprof:oso/9780195306637.003.0012
8. Chen, C. T., Hwang, L. L., Chang, J. K., and Dun, N. J. (2000). Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am. J. Physiol. 278, R692-R697.
9. Ciriello, J., Caverson, M. M., McMurray, J. C., and Bruckschwaiger, E. B. (2013). Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure. Neuroscience 250, 599-613. doi: 10.1016/j.neuroscience.2013.07.054
10. Ciriello, J., and De Oliveira, C. V. R. (2003). Cardiac effects of hypocretin-1 in nucleus ambiguus. Am. J. Physiol. 284, R1611-R1620. doi: 10.1152/ajpregu.00719.2002
11. Ciriello, J., Li, Z., and De Oliveira, C. V. R. (2003). Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla. Brain Res. 991, 84-95. doi: 10.1016/j.brainres.2003.08.008
12. Cluderay, J. E., Harrison, D. C., and Hervieu, G. J. (2002). Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul. Peptides 104, 131-144. doi: 10.1016/S0167-0115(01)00357-3
13. Date, Y., Mondal, M. S., Matsukura, S., and Nakazato, M. (2000). Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci. Lett. 288, 87-90. doi: 10.1016/S0304-3940(00)01195-2
14. Dauvilliers, Y., Jaussent, I., Krams, B., Scholz, S., Lado, S., Levy, P., et al. (2012). Non-dipping blood pressure profile in narcolepsy with cataplexy. PLoS ONE 7:e38977. doi: 10.1371/journal.pone.0038977
15. De Oliveira, C. V. R., Rosas-Arellano, M. P., Solano-Flores, L. P., and Ciriello, J. (2003). Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am. J. Physiol. 284, H1369-H1377. doi: 10.1152/ajpheart.00877.2002
16. Dun, N. J., Le Dun, S., Chen, C. T., Hwang, L. L., Kwok, E. H., and Chang, J. K. (2000). Orexins: a role in medullary sympathetic outflow. Regul. Peptides 96, 65-70. doi: 10.1016/S0167-0115(00)00202-0
17. Furlong, T. M., Vianna, D. M. L., Liu, L., and Carrive, P. (2009). Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur. J. Neurosci. 30, 1603-1614. doi: 10.1111/j.1460-9568.2009.06952.x
18. Gotter, A. L., Webber, A. L., Coleman, P. J., Renger, J. J., and Winrow, C. J. (2012). International union of basic and clinical pharmacology. LXXXVI. orexin receptor function, nomenclature and pharmacology. Pharmacol. Rev. 64, 389-420. doi: 10.1124/pr.111.005546
19. Grimaldi, D., Calandra-Buonaura, G., Provini, F., Agati, P., Pierangeli, G., Franceschini, C., et al. (2012). Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep 35, 519-528. doi: 10.5665/sleep.1738
20. Grimaldi, D., Pierangeli, G., Barletta, G., Terlizzi, R., Plazzi, G., Cevoli, S., et al. (2010). Spectral analysis of heart rate variability reveals an enhanced sympathetic activity in narcolepsy with cataplexy. Clin. Neurophysiol. 121, 1142-1147. doi: 10.1016/j.clinph.2010.01.028
21. Hervieu, G. J., Cluderay, J. E., Harrison, D. C., Roberts, J. C., and Leslie, R. A. (2001). Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103, 777-797. doi: 10.1016/S0306-4522(01)00033-1
22. Hilton, S. M. (1982). The defence-arousal system and its relevance for circulatory and respiratory control. J. Exp. Biol. 100, 159-174.
23. Hirose, M., Egashira, S.-I., Goto, Y., Hashihayata, T., Ohtake, N., Iwaasa, H., et al. (2003). N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg. Med. Chem. Lett. 13, 4497-4499. doi: 10.1016/j.bmcl.2003.08.038
24. Hirota, K., Kushikata, T., Kudo, M., Kudo, T., Smart, D., and Matsuki, A. (2003). Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res. 981, 143-150. doi: 10.1016/S0006-8993(03)03002-6
25. Huang, S.-C., Dai, Y.-W. E., Lee, Y.-H., Chiou, L.-C., and Hwang, L.-L. (2010). Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors. J. Pharmacol. Exp. Ther. 334, 522-529. doi: 10.1124/jpet.110.167791
26. Iigaya, K., Horiuchi, J., McDowall, L. M., Lam, A. C. B., Sediqi, Y., Polson, J. W., et al. (2012). Blockade of orexin receptors with Almorexant reduces cardiorespiratory responses evoked from the hypothalamus but not baro-or chemoreceptor reflex responses. Am. J. Physiol. 303, R1011-R1022. doi: 10.1152/ajpregu.00263.2012
27. Johnson, P. L., Samuels, B. C., Fitz, S. D., Federici, L. M., Hammes, N., Early, M. C., et al. (2012a). Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol. Behav. 107, 733-742. doi: 10.1016/j.physbeh.2012.04.016
28. Johnson, P. L., Samuels, B. C., Fitz, S. D., Lightman, S. L., Lowry, C. A., and Shekhar, A. (2012b). Activation of the orexin 1 receptor is a critical component of CO(2)-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology 37, 1911-1922. doi: 10.1038/npp.2012.38.
29. Johnson, P. L., Truitt, W., Fitz, S. D., Minick, P. E., Dietrich, A., Sanghani, S., et al. (2009). A key role for orexin in panic anxiety. Nat. Med. 16, 111-115. doi: 10.1038/nm.2075
30. Kayaba, Y., Nakamura, A., Kasuya, Y., Ohuchi, T., Yanagisawa, M., Komuro, I., et al. (2003). Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. 285, R581-R593. doi: 10.1152/ajpregu.00671.2002
31. Lee, Y.-H., Dai, Y.-W. E., Huang, S.-C., Li, T. L., and Hwang, L.-L. (2013). Blockade of central orexin 2 receptors reduces arterial pressure in spontaneously hypertensive rats. Exp. Physiol. 98, 1145-1155. doi: 10.1113/expphysiol.2013.072298
32. Li, A., Hindmarch, C. C. T., Nattie, E. E., and Paton, J. F. R. (2013). Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats. J. Physiol. doi: 10.1113/jphysiol.2013.256271. [Epub ahead of print].
33. Llewellyn-Smith, I. J., Martin, C. L., Marcus, J. N., Yanagisawa, M., Minson, J. B., and Scammell, T. E. (2003). Orexin-immunoreactive inputs to rat sympathetic preganglionic neurons. Neurosci. Lett. 351, 115-119. doi: 10.1016/S0304-3940(03)00770-5
34. Lo Martire, V., Silvani, A., Bastianini, S., Berteotti, C., and Zoccoli, G. (2012). Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons. PLoS ONE 7:e47032. doi: 10.1371/journal.pone.0047032
35. Lu, X. Y., Bagnol, D., Burke, S., Akil, H., and Watson, S. J. (2000). Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav. 37, 335-344. doi: 10.1006/hbeh.2000.1584
36. Luong, L. N. L., and Carrive, P. (2012). Orexin microinjection in the medullary raphe increases heart rate and arterial pressure but does not reduce tail skin blood flow in the awake rat. Neuroscience 202, 209-217. doi: 10.1016/j.neuroscience.2011.11.073
37. Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., et al. (2001). Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6-25. doi: 10.1002/cne.1190
38. Morairty, S. R., Revel, F. G., Malherbe, P., Moreau, J.-L., Valladao, D., Wettstein, J. G., et al. (2012). Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PLoS ONE 7:e39131. doi: 10.1371/journal.pone.0039131
39. Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., and Goto, K. (1999). Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243-260. doi: 10.1016/S0006-8993(99)01336-0
40. Nisimaru, N., Mittal, C., Shirai, Y., Sooksawate, T., Anandaraj, P., Hashikawa, T., et al. (2013). Orexin-neuromodulated cerebellar circuit controls redistribution of arterial blood flows for defense behavior in rabbits. Proc. Natl. Acad. Sci. U.S.A. 110, 14124-14131. doi: 10.1073/pnas.1312804110
41. Peyron, C., Tighe, D. K., Van Den Pol, A. N., De Lecea, L., Heller, H. C., Sutcliffe, J. G., et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015.
42. Rusyniak, D. E., Zaretsky, D. V., Zaretskaia, M. V., and Dimicco, J. A. (2011). The role of orexin-1 receptors in physiologic responses evoked by microinjection of PgE2 or muscimol into the medial preoptic area. Neurosci. Lett. 498, 162-166. doi: 10.1016/j.neulet.2011.05.006
43. Rusyniak, D. E., Zaretsky, D. V., Zaretskaia, M. V., Durant, P. J., and Dimicco, J. A. (2012). The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress. Physiol. Behav. 107, 743-750. doi: 10.1016/j.physbeh.2012.02.010
44. Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., et al. (2005). Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46, 297-308. doi: 10.1016/j.neuron.2005.03.010
45. Samson, W. K., Bagley, S. L., Ferguson, A. V., and White, M. M. (2007). Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am. J. Physiol. 292, R382-R387. doi: 10.1152/ajpregu.00496.2006
46. Samson, W. K., Gosnell, B., Chang, J. K., Resch, Z. T., and Murphy, T. C. (1999). Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 831, 248-253.
47. Saper, C. B. (2004). "Central autonomic nervous system," in The Rat Nervous System, 3rd Edn., ed G. Paxinos (San Diego, CA: Elsevier), 761-794.
48. Scammell, T. E., and Winrow, C. J. (2011). Orexin receptors: pharmacology and therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol. 51, 243-266. doi: 10.1146/annurev-pharmtox-010510-100528
49. Shahid, I. Z., Rahman, A. A., and Pilowsky, P. M. (2011). Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex. Br. J. Pharmacol. 162, 961-973. doi: 10.1111/j.1476-5381.2010.01102.x
50. Shahid, I. Z., Rahman, A. A., and Pilowsky, P. M. (2012). Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex. Br. J. Pharmacol. 165, 2292-2303. doi: 10.1111/j.1476-5381.2011.01694.x
51. Shih, C.-D., and Chuang, Y.-C. (2007). Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats. Neuroscience 149, 625-635. doi: 10.1016/j.neuroscience.2007.07.016
52. Shirasaka, T., Nakazato, M., Matsukura, S., Takasaki, M., and Kannan, H. (1999). Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277, R1780-R1785.
53. Silvani, A., Bastianini, S., Berteotti, C., Cenacchi, G., Leone, O., Lo Martire, V., et al. (2013). Sleep and cardiovascular phenotype in middle-aged hypocretin-deficient narcoleptic mice. J. Sleep Res. doi: 10.1111/jsr.12081. [Epub ahead of print].
54. Sorensen, G. L., Knudsen, S., Petersen, E. R., Kempfner, J., Gammeltoft, S., Sorensen, H. B. D., et al. (2013). Attenuated heart rate response is associated with hypocretin deficiency in patients with narcolepsy. Sleep 36, 91-98. doi: 10.5665/sleep.2308
55. Steiner, M. A., Gatfield, J., Brisbare-Roch, C., Dietrich, H., Treiber, A., Jenck, F., et al. (2013). Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonist. ChemMedChem 8, 898-903. doi: 10.1002/cmdc.201300003
56. Stettner, G. M., and Kubin, L. (2013). Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus. J. Appl. Physiol. 114, 119-130. doi: 10.1152/japplphysiol.00965.2012
57. Trivedi, P., Yu, H., Macneil, D. J., Van Der Ploeg, L. H., and Guan, X. M. (1998). Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438, 71-75. doi: 10.1016/S0014-5793(98)01266-6
58. Tucci, V., Stegagno, L., Vandi, S., Ferrillo, F., Palomba, D., Vignatelli, L., et al. (2003). Emotional information processing in patients with narcolepsy: a psychophysiologic investigation. Sleep 26, 558-564.
59. Van Den Pol, A. N. (1999). Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 19, 3171-3182.
60. Van Den Top, M., Nolan, M. F., Lee, K., Richardson, P. J., Buijs, R. M., Davies, C. H., et al. (2003). Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J. Physiol. 549, 809-821. doi: 10.1113/jphysiol.2002.033290
61. Xiao, F., Jiang, M., Du, D., Xia, C., Wang, J., Cao, Y., et al. (2012). Orexin A regulates cardiovascular responses in stress-induced hypertensive rats. Neuropharmacology 67C, 16-24. doi: 10.1016/j.neuropharm.2012.10.021
62. Yamanaka, A., Tabuchi, S., Tsunematsu, T., Fukazawa, Y., and Tominaga, M. (2010). Orexin directly excites orexin neurons through orexin 2 receptor. J. Neurosci. 30, 12642-12652. doi: 10.1523/JNEUROSCI.2120-10.2010
63. Yoshida, K., McCormack, S., España, R. A., Crocker, A., and Scammell, T. E. (2006). Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845-861. doi: 10.1002/cne.20859
64. Zheng, H., Patterson, L. M., and Berthoud, H.-R. (2005). Orexin-A projections to the caudal medulla and orexin-induced c-Fos expression, food intake, and autonomic function. J. Comp. Neurol. 485, 127-142. doi: 10.1002/cne.20515